Thursday, March 31, 2016 | Larry Sobal

Imagine that you’re in a new entry-level college class, but with a few twists. You’ve seen your tuition stabilize after years of a threatened increase of more than 20%. There are some old policies still in place that might cost you up to nine percent in 2017 (depending on whether you’re doing the right things this year) and a yet-to-be-determined penalty in 2018 before those programs expire. One of them, which we’ll call VBPM, has a financial impact to you in 2017, but it’s too late for you to impact it because it was based on 2015 grades. Not to confuse you further, but there are a bunch of new programs that may reward or penalize you starting in 2019—and they'll be determined by how you perform in 2017. You'll have to pick between one of two tracks, depending on which presents the greatest upside, given your performance and capabilities.
Welcome to MACRAnomics 101. Did I mention that this was a required course for all physicians who see Medicare patients?
Don't worry. The committee that oversees all these programs just met on March 17 to get feedback on the design of how this all works, especially how you’ll be graded and how financial rewards and penalties will be applied in the future, since it’s not totally defined today. I’m sure you can trust them since they have a very official-sounding name (House Energy and Commerce Committee) and, after all, they’re here to help you, right?
If all of this sounds crazy, welcome to MACRAnomics 101. Did I mention that this was a required course for all physicians who see Medicare patients?
For those of you who skipped out on the lectures, or slept through most of them, I'll make it easy for you. Here's a summary of my notes to help you understand the major points so you can make the honor roll.
In April 2015, President Obama signed into law the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), which has 3 key parts to remember:
If you can understand those three points, you’ll score ahead of the curve on the final exam.
The reality is that this is pretty complicated. As is usually the case in Washington, legislation meant to address one issue morphed into a larger bill, as legislative members dropped in a variety of other pending items or pet projects. MACRA was no different. So, in addition to simply replacing the SGR methodology, there are many other Medicare programs and categories of reimbursement that were piled in. The confusion-to-complication ratio falls just below the Affordable Care Act.
Fortunately, like most college students, many others in your class will procrastinate when they realize that the new payment incentives won't go live until 2019, based on performance in 2017. Instead, they'll be planning a toga party to celebrate MACRA’s first birthday on April 16, which, conveniently, is a Saturday.
So, how would you grade yourself regarding your knowledge and readiness for MACRA? Are you getting an “A” (you fully understand MACRA, have viewed your QRUR, and are prepared to optimize the incentives), or an “F” (you haven't paid any attention to MACRA, don't know what your QRUR is, and are at risk for the maximum penalties)? Are you somewhere in between?
Learn more about MACRA at our MACRA-specific Resource Center--and don't miss the MACRA Readiness webinar on April 26!
Larry Sobal is Executive Vice President of Business Development at MedAxiom. He has a 35-year background as a senior executive in medical group leadership, hospital leadership and insurance. As part of his current role, Larry consults, writes and presents on topics relevant to transforming physician practices and health systems.
Larry Sobal, MBA, MHA, is CEO of a yet-to-be-named cardiology practice which is transitioning from employment to an independent physician group effective January 1, 2019. He has a 37-year background as a senior executive in physician practices, consulting, medical group leadership, hospital leadership and health insurance.
To contact, email: [email protected]
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
Leave a Comment